|
|
Volumn 308, Issue 9, 2012, Pages 850-851
|
|
European drug agency works to improve transparency, but skepticism remains
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG INDUSTRY;
DRUG RESEARCH;
EUROPEAN UNION;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HEALTH CARE POLICY;
MENTAL HEALTH SERVICE;
PHARMACOECONOMICS;
PHARMACOEPIDEMIOLOGY;
PRIORITY JOURNAL;
SHORT SURVEY;
WORKSHOP;
WORLD HEALTH ORGANIZATION;
ACCESS TO INFORMATION;
CLINICAL TRIAL (TOPIC);
EUROPE;
INTERPERSONAL COMMUNICATION;
NOTE;
PUBLISHING;
ACCESS TO INFORMATION;
CLINICAL TRIALS AS TOPIC;
DISCLOSURE;
DRUG INDUSTRY;
EUROPE;
GOVERNMENT AGENCIES;
PUBLISHING;
|
|
EID: 84865680521
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/2012.jama.10451 Document Type: Short Survey |
|
Times cited : (6)
|
|
References (0)
|
